###begin article-title 0
The sympathetic tone mediates leptin's inhibition of insulin secretion by modulating osteocalcin bioactivity
###end article-title 0
###begin p 1
###xml 35 54 35 54 <email xmlns:xlink="http://www.w3.org/1999/xlink">gk2172@columbia.edu</email>
Correspondence to Gerard Karsenty: gk2172@columbia.edu
###end p 1
###begin p 2
This article is distributed under the terms of an Attribution-Noncommercial-Share Alike-No Mirror Sites license for the first six months after the publication date (see ). After six months it is available under a Creative Commons License (Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at ).
###end p 2
###begin p 3
###xml 498 501 498 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esp</italic>
###xml 597 600 597 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esp</italic>
###xml 673 678 673 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 693 704 693 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Osteocalcin</italic>
###xml 679 683 <span type="species:ncbi:10090">mice</span>
The osteoblast-secreted molecule osteocalcin favors insulin secretion, but how this function is regulated in vivo by extracellular signals is for now unknown. In this study, we show that leptin, which instead inhibits insulin secretion, partly uses the sympathetic nervous system to fulfill this function. Remarkably, for our purpose, an osteoblast-specific ablation of sympathetic signaling results in a leptin-dependent hyperinsulinemia. In osteoblasts, sympathetic tone stimulates expression of Esp, a gene inhibiting the activity of osteocalcin, which is an insulin secretagogue. Accordingly, Esp inactivation doubles hyperinsulinemia and delays glucose intolerance in ob/ob mice, whereas Osteocalcin inactivation halves their hyperinsulinemia. By showing that leptin inhibits insulin secretion by decreasing osteocalcin bioactivity, this study illustrates the importance of the relationship existing between fat and skeleton for the regulation of glucose homeostasis.
###end p 3
###begin p 4
Abbreviations used in this paper: HA, hydroxyapatite; ICV, intracerebroventricular; ITT, insulin tolerance test; WT, wild type.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 166 187 166 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">Herman and Kahn, 2006</xref>
###xml 189 207 189 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">Gesta et al., 2007</xref>
###xml 209 225 209 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">Lee et al., 2007</xref>
###xml 500 516 497 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">Lee et al., 2007</xref>
###xml 645 656 638 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">B&#252;gel, 2008</xref>
Our understanding of the mechanisms regulating insulin secretion at the organismal level improved greatly recently with the identification of several novel hormones (Herman and Kahn, 2006; Gesta et al., 2007; Lee et al., 2007). It was shown, for instance, that skeleton acts as an endocrine regulator of energy metabolism through the osteoblast-specific secreted molecule osteocalcin that favors insulin secretion by beta cells, insulin sensitivity in fat, liver, and muscle, and energy expenditure (Lee et al., 2007). Although osteocalcin bioactivity is regulated by at least two gene products within the osteoblast, Esp and gamma-carboxylase (Bugel, 2008), it remains unknown whether extracellular cues regulate its secretion or function.
###end p 6
###begin p 7
###xml 109 127 106 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">Covey et al., 2006</xref>
###xml 129 149 126 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">Morioka et al., 2007</xref>
###xml 235 260 232 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">Friedman and Halaas, 1998</xref>
###xml 262 287 259 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">Kieffer and Habener, 2000</xref>
###xml 435 452 432 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">Ducy et al., 2000</xref>
###xml 454 473 451 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">Takeda et al., 2002</xref>
In contrast to osteocalcin, leptin inhibits insulin secretion in part through a direct effect on beta cells (Covey et al., 2006; Morioka et al., 2007) and, as is the case for most of its functions, in part through indirect mechanisms (Friedman and Halaas, 1998; Kieffer and Habener, 2000). Leptin affects osteoblast functions, raising the testable hypothesis that it could inhibit insulin secretion by decreasing osteocalcin activity (Ducy et al., 2000; Takeda et al., 2002).
###end p 7
###begin p 8
In this study, we show that one important mechanism whereby leptin inhibits insulin secretion is by inhibiting the bioactivity of osteocalcin. These results provide in vivo evidence of the importance of the cross talk existing between osteoblasts and adipocytes in glucose homeostasis.
###end p 8
###begin title 9
Results and discussion
###end title 9
###begin title 10
Regulation of insulin secretion by leptin
###end title 10
###begin p 11
###xml 261 266 261 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 455 463 455 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 268 272 <span type="species:ncbi:10090">mice</span>
The fact that leptin and osteocalcin exert opposite functions on insulin secretion prompted us to test whether they act independently of each other or not. To avoid the confounding issue of insulin resistance, we analyzed insulin secretion in leptin-deficient (ob/ob) mice at birth and 1 and 2 wk of age because at those ages body weight, abdominal and total fat mass, triglyceride level, and insulin sensitivity are not altered by the absence of leptin (Fig. 1 A and Fig. S1, A-D, available at ).
###end p 11
###begin p 12
###xml 0 72 0 72 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Leptin regulates insulin secretion in part through the neuronal pathway.</bold>
###xml 93 98 93 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 150 155 150 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 216 221 216 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 306 311 306 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 693 698 687 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 704 707 698 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L/L</italic>
###xml 755 758 749 752 <sub xmlns:xlink="http://www.w3.org/1999/xlink">syn</sub>
###xml 758 761 752 755 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 751 761 745 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lepr<sub>syn</sub><sup>&#8722;/&#8722;</sup></italic>
###xml 891 903 885 897 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Synapsin-Cre</italic>
###xml 99 103 <span type="species:ncbi:10090">mice</span>
###xml 156 160 <span type="species:ncbi:10090">mice</span>
###xml 222 226 <span type="species:ncbi:10090">mice</span>
###xml 312 316 <span type="species:ncbi:10090">mice</span>
###xml 393 397 <span type="species:ncbi:10090">mice</span>
###xml 473 477 <span type="species:ncbi:10090">mice</span>
###xml 615 619 <span type="species:ncbi:10090">mice</span>
###xml 708 712 <span type="species:ncbi:10090">mice</span>
###xml 762 766 <span type="species:ncbi:10090">mice</span>
###xml 904 908 <span type="species:ncbi:10090">mice</span>
Leptin regulates insulin secretion in part through the neuronal pathway. (A) ITT in 2-wk-old ob/ob mice. (B and C) Serum insulin and blood glucose in ob/ob mice. (D) Gene expression in pancreas or islets of 2-wk-old ob/ob mice. (E) Quantification of insulin/Ki67 immunoreactive cells in islets of 2-wk-old ob/ob mice. (F and G) Serum insulin and blood glucose in adipocyte-deficient (adp-def) mice. (H) Gene expression in pancreas or islets of 2-wk-old adipocyte-deficient mice. (I-K) Quantification of insulin/Ki67 immunoreactive cells in islets, beta-cell area, and beta-cell mass of 2-wk-old adipocyte-deficient mice. (L-N) Glucose-stimulated insulin secretion by leptin in islets from WT, ob/ob, and L/L mice. (O) Serum insulin levels in 1-mo-old Leprsyn-/- mice. Error bars indicate mean + SEM. *, P < 0.05; **, P < 0.01; P1, newborn; 1W, 1 wk old; 2W, 2 wk old. Control in O indicates Synapsin-Cre mice. In L-N, the concentration of glucose in the culture media is indicated in millimolars.
###end p 12
###begin p 13
###xml 12 17 12 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 270 275 270 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 282 297 282 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, B and C</xref>
###xml 476 481 473 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 506 513 503 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Insulin</italic>
###xml 527 538 524 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Glucokinase</italic>
###xml 608 626 602 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">Grupe et al., 1995</xref>
###xml 674 679 668 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 686 694 680 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 D</xref>
###xml 819 824 813 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 929 934 923 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 985 989 979 983 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdk4</italic>
###xml 1040 1057 1031 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">Rane et al., 1999</xref>
###xml 1084 1089 1075 1080 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 1182 1187 1170 1175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 1211 1226 1199 1214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, D and E</xref>
###xml 18 22 <span type="species:ncbi:10090">mice</span>
###xml 276 280 <span type="species:ncbi:10090">mice</span>
###xml 359 363 <span type="species:ncbi:10090">mice</span>
###xml 482 486 <span type="species:ncbi:10090">mice</span>
###xml 680 684 <span type="species:ncbi:10090">mice</span>
###xml 825 829 <span type="species:ncbi:10090">mice</span>
###xml 1205 1209 <span type="species:ncbi:10090">mice</span>
In 2-wk-old ob/ob mice serum, insulin levels were 2.5-fold higher than in wild-type (WT) littermates, resulting in a >30% decrease of blood glucose levels after feeding. Remarkably, hyperinsulinemia and low blood glucose levels were also present in newborn and 1-wk-old ob/ob mice (Fig. 1, B and C). To understand how this marked hyperinsulinemia develops in mice that are otherwise metabolically normal, we studied islet gene expression and beta-cell proliferation in WT and ob/ob mice. Expression of the Insulin genes and of Glucokinase, a central component of the glucose-sensing machinery of beta cells (Grupe et al., 1995), was increased 50% and 140%, respectively, in ob/ob mice (Fig. 1 D), at least partly explaining the aforementioned increased insulin levels. Serum c-peptide levels were increased 2.5-fold in ob/ob mice (Fig. S1 E). There was also a small but detectable and reproducible increase in insulin content in ob/ob pancreata (Fig. S1 F). In addition, expression of Cdk4, a gene favoring beta-cell proliferation in vivo (Rane et al., 1999), was up-regulated 50% in ob/ob islets, and Ki67 immunostaining showed a significant increase in beta-cell proliferation in ob/ob compared with WT mice (Fig. 1, D and E). Undetectable increases in beta-cell area and beta-cell mass (Fig. S1, G and H) indicate that the absence of leptin affects circulating insulin levels primarily by regulating insulin expression and secretion in addition to the possibility of changes of cell survival. Nevertheless, these results establish that leptin is a physiological regulator of serum insulin levels independent of the influence it may have on insulin sensitivity.
###end p 13
###begin p 14
###xml 263 278 263 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, F and G</xref>
###xml 317 324 317 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Insulin</italic>
###xml 326 337 326 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Glucokinase</italic>
###xml 343 347 343 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdk4</italic>
###xml 421 426 421 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 433 441 433 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 H</xref>
###xml 645 656 642 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, I&#8211;K</xref>
###xml 931 936 925 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 1033 1040 1027 1034 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Insulin</italic>
###xml 1045 1056 1039 1050 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Glucokinase</italic>
###xml 55 59 <span type="species:ncbi:10090">mice</span>
###xml 120 124 <span type="species:ncbi:10090">mice</span>
###xml 427 431 <span type="species:ncbi:10090">mice</span>
###xml 525 529 <span type="species:ncbi:10090">mice</span>
###xml 639 643 <span type="species:ncbi:10090">mice</span>
###xml 788 792 <span type="species:ncbi:10090">mice</span>
###xml 961 965 <span type="species:ncbi:10090">mice</span>
###xml 1188 1192 <span type="species:ncbi:10090">mice</span>
###xml 1207 1211 <span type="species:ncbi:10090">mice</span>
We asked whether similar abnormalities were present in mice lacking adipocytes altogether. 2-wk-old adipocyte-deficient mice were also markedly hyperinsulinemic and had a significant drop in blood glucose levels; this hyperinsulinemia was also observed at birth (Fig. 1, F and G; and Fig. S1, I and J). Expression of Insulin, Glucokinase, and Cdk4 was up-regulated to the same extent in islets of adipocyte-deficient and ob/ob mice (Fig. 1 H), and insulin content was significantly increased in islets of adipocyte-deficient mice (Fig. S1 K). beta-cell proliferation, area, and mass were all significantly increased in adipocyte-deficient mice (Fig. 1, I-K; and Fig. S1 L). Collectively, and although insulin resistance may have favored beta-cell proliferation in the adipocyte-deficient mice, the data presented here show that hyperinsulinemia and lower blood glucose levels precede the appearance of obesity and hyperglycemia in ob/ob and adipocyte-deficient mice, respectively, and can be ascribed in both cases to an increase in Insulin and Glucokinase expression and, to a lesser extent, to an increase in beta-cell proliferation. More severe hyperinsulinemia in adipocyte-deficient mice than in ob/ob mice indicates that in addition to leptin deficiency, other mechanisms affect insulin secretion in the former model.
###end p 14
###begin title 15
Multiple mechanisms contribute to leptin regulation of insulin secretion
###end title 15
###begin p 16
###xml 280 285 280 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 294 309 294 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, L and M</xref>
###xml 571 579 568 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 B</xref>
###xml 712 715 709 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L/L</italic>
###xml 722 744 719 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">Bj&#246;rnholm et al., 2007</xref>
###xml 939 947 933 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 N</xref>
###xml 1206 1211 1200 1205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 1217 1220 1211 1214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L/L</italic>
###xml 650 654 <span type="species:ncbi:10090">mice</span>
###xml 716 720 <span type="species:ncbi:10090">mice</span>
###xml 1221 1225 <span type="species:ncbi:10090">mice</span>
Next, we studied leptin influence on isolated islets. When using WT islets cultured in low or high glucose concentration, we failed to observe a decrease in the amount of insulin secreted in the medium after leptin treatment. In contrast, leptin did decrease insulin secretion by ob/ob islets (Fig. 1, L and M). This result supports the notion that this hormone acts directly on beta cells to regulate insulin secretion; however, the decrease observed was too modest to explain why the absence of leptin would result in a 2.5-fold increase in circulating insulin levels (Fig. 1 B). In the face of these results, we asked whether islets isolated from mice harboring an activating mutation in the leptin receptor (L/L mice; Bjornholm et al., 2007) might be a better tool to uncover a more significant direct effect of leptin on beta cells. In this study, again we observed only a modest decrease in insulin secretion after leptin treatment (Fig. 1 N). The marked increase in insulin secretion by high glucose concentration served as an internal positive control and indicated that the islets used in all of these experiments were in good condition. Collectively, data obtained using islets isolated from WT, ob/ob, and L/L mice verified that leptin acts locally on beta cells to inhibit insulin secretion but were also consistent with the hypothesis that in addition to this direct effect, leptin may use indirect mechanisms to regulate insulin secretion.
###end p 16
###begin title 17
Leptin-dependent sympathetic regulation of insulin secretion
###end title 17
###begin p 18
###xml 260 264 260 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lepr</italic>
###xml 266 280 266 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lepr-flox/flox</italic>
###xml 287 299 287 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Synapsin-Cre</italic>
###xml 362 386 362 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">van de Wall et al., 2008</xref>
###xml 398 410 398 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Synapsin-Cre</italic>
###xml 411 425 411 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lepr-flox/flox</italic>
###xml 431 434 431 434 <sub xmlns:xlink="http://www.w3.org/1999/xlink">syn</sub>
###xml 434 437 434 437 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 427 437 427 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lepr<sub>syn</sub><sup>&#8722;/&#8722;</sup></italic>
###xml 646 654 646 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 O</xref>
###xml 201 205 <span type="species:ncbi:10090">mice</span>
###xml 300 315 <span type="species:ncbi:10090">transgenic mice</span>
###xml 439 443 <span type="species:ncbi:10090">mice</span>
Given what is known about the mediation of most of its functions, the aforementioned results prompted us to ask whether leptin also uses a neuronal relay to inhibit insulin secretion. Thus, we crossed mice harboring a floxed allele of the leptin receptor gene Lepr (Lepr-flox/flox) with Synapsin-Cre transgenic mice to remove the leptin receptor in all neurons (van de Wall et al., 2008). 1-mo-old Synapsin-Cre;Lepr-flox/flox (Leprsyn-/-) mice had a normal body weight but harbored a significant increase in serum insulin levels, indicating that in vivo there is a significant neuronal contribution to the leptin regulation of insulin secretion (Fig. 1 O and Fig. S1 M).
###end p 18
###begin p 19
###xml 21 24 21 24 <sub xmlns:xlink="http://www.w3.org/1999/xlink">syn</sub>
###xml 24 27 24 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 17 27 17 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lepr<sub>syn</sub><sup>&#8722;/&#8722;</sup></italic>
###xml 67 71 67 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ucp1</italic>
###xml 157 168 157 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, A&#8211;C</xref>
###xml 217 222 217 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 358 387 358 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">Berthoud and Jeanrenaud, 1979</xref>
###xml 394 399 394 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 832 837 821 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 868 883 857 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, D and E</xref>
###xml 910 914 899 903 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ucp1</italic>
###xml 1035 1043 1024 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 F</xref>
###xml 1213 1217 1202 1206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ucp1</italic>
###xml 1290 1298 1279 1287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 F</xref>
###xml 28 32 <span type="species:ncbi:10090">mice</span>
###xml 223 227 <span type="species:ncbi:10090">mice</span>
###xml 696 701 <span type="species:ncbi:10090">mouse</span>
###xml 862 866 <span type="species:ncbi:10090">mice</span>
###xml 1101 1105 <span type="species:ncbi:10090">mice</span>
###xml 1267 1271 <span type="species:ncbi:10090">mice</span>
We noted that in Leprsyn-/- mice, sympathetic tone, as measured by Ucp1 expression in brown fat and serum levels of epinephrine and norepinephrine, was low (Fig. 2, A-C). This decrease, similar to the one observed in ob/ob mice, led us to ask whether the sympathetic tone could be a mediator of the leptin-dependent neuronal regulation of insulin secretion (Berthoud and Jeanrenaud, 1979). WT, ob/ob, and adipocyte-deficient newborn pups were treated for 2 wk with sympathomimetics acting through beta-adrenergic receptors (isoproterenol) or through the Adralpha2 (clonidine) or Adralpha1 (phenylephrine) receptors. Neither phenylephrine nor clonidine affected serum insulin levels in any of the mouse models tested; in contrast, isoproterenol used at a moderate dose (3 mg/kg) significantly decreased circulating insulin levels in ob/ob and adipocyte-deficient mice (Fig. 2, D and E). Isoproterenol increased Ucp1 expression in brown fat, supporting the notion that there was an increase in sympathetic tone following this treatment (Fig. 2 F). Isoproterenol did not affect circulating insulin in WT mice, probably because it was used at a dose that did not cause a massive increase in sympathetic tone. Indeed, Ucp1 expression was not significantly increased in WT mice by isoproterenol (Fig. 2 F). Collectively, these observations establish that the sympathetic tone acting through beta-adrenergic receptors regulates insulin secretion.
###end p 19
###begin p 20
###xml 0 80 0 80 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Sympathetic signaling in osteoblasts regulates insulin expression and secretion.</bold>
###xml 85 89 85 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ucp1</italic>
###xml 121 124 121 124 <sub xmlns:xlink="http://www.w3.org/1999/xlink">syn</sub>
###xml 124 127 124 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 117 127 117 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lepr<sub>syn</sub><sup>&#8722;/&#8722;</sup></italic>
###xml 195 198 195 198 <sub xmlns:xlink="http://www.w3.org/1999/xlink">syn</sub>
###xml 198 201 198 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 191 201 191 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lepr<sub>syn</sub><sup>&#8722;/&#8722;</sup></italic>
###xml 242 247 242 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 387 391 387 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ucp1</italic>
###xml 419 424 419 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 536 539 533 536 <sub xmlns:xlink="http://www.w3.org/1999/xlink">osb</sub>
###xml 539 542 536 539 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 528 542 528 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Adr&#946;2<sub>osb</sub><sup>&#8722;/&#8722;</sup></italic>
###xml 592 595 586 589 <sub xmlns:xlink="http://www.w3.org/1999/xlink">osb</sub>
###xml 595 598 589 592 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 584 598 581 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Adr&#946;2<sub>osb</sub><sup>&#8722;/&#8722;</sup></italic>
###xml 729 732 720 723 <sub xmlns:xlink="http://www.w3.org/1999/xlink">osb</sub>
###xml 732 735 723 726 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 721 735 715 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Adr&#946;2<sub>osb</sub><sup>&#8722;/&#8722;</sup></italic>
###xml 782 789 773 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Insulin</italic>
###xml 829 831 820 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob</italic>
###xml 842 845 830 833 <sub xmlns:xlink="http://www.w3.org/1999/xlink">osb</sub>
###xml 834 845 825 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Adr&#946;2<sub>osb</sub></italic>
###xml 845 848 833 836 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 934 937 919 922 <sub xmlns:xlink="http://www.w3.org/1999/xlink">osb</sub>
###xml 937 940 922 925 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 926 940 914 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Adr&#946;2<sub>osb</sub><sup>&#8722;/&#8722;</sup></italic>
###xml 1081 1084 1063 1066 <sub xmlns:xlink="http://www.w3.org/1999/xlink">osb</sub>
###xml 1084 1087 1066 1069 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1073 1087 1058 1069 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Adr&#946;2<sub>osb</sub><sup>&#8722;/&#8722;</sup></italic>
###xml 1234 1246 1216 1228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Synapsin-Cre</italic>
###xml 1284 1305 1266 1283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#945;1(I)Collagen-Cre</italic>
###xml 128 132 <span type="species:ncbi:10090">mice</span>
###xml 202 206 <span type="species:ncbi:10090">mice</span>
###xml 282 286 <span type="species:ncbi:10090">mice</span>
###xml 449 453 <span type="species:ncbi:10090">mice</span>
###xml 543 547 <span type="species:ncbi:10090">mice</span>
###xml 599 603 <span type="species:ncbi:10090">mice</span>
###xml 736 740 <span type="species:ncbi:10090">mice</span>
###xml 849 853 <span type="species:ncbi:10090">mice</span>
###xml 941 945 <span type="species:ncbi:10090">mice</span>
###xml 1088 1092 <span type="species:ncbi:10090">mice</span>
###xml 1247 1251 <span type="species:ncbi:10090">mice</span>
###xml 1306 1310 <span type="species:ncbi:10090">mice</span>
Sympathetic signaling in osteoblasts regulates insulin expression and secretion. (A) Ucp1 expression in brown fat of Leprsyn-/- mice. (B and C) Serum epinephrine and norepinephrine levels in Leprsyn-/- mice. (D and E) Serum insulin levels in ob/ob and adipocyte-deficient (adp-def) mice after daily isoproterenol (+ISO), phenylephrine (+Phe), or clonidine (+Clo) injection for 2 wk. (F) Ucp1 expression in brown fat of ob/ob and adipocyte-deficient mice after daily isoproterenol injection. (G) Serum insulin levels in 2-wk-old Adrbeta2osb-/- mice. (H) Serum insulin levels in WT and Adrbeta2osb-/- mice after daily propranolol injection for 2 wk. (I and J) Blood glucose levels and gene expression in islets of 2-wk-old Adrbeta2osb-/- mice. (K-M) Serum insulin, blood glucose, and Insulin expression in the pancreas of 2-wk-old ob/+;Adrbeta2osb+/- mice. (N) Delta insulin after glucose-stimulated insulin secretion in WT and Adrbeta2osb-/- mice treated with central leptin infusion at 4 ng/h for 1 wk. (O and P) Plasma insulin levels during hyperglycemic clamps in WT and Adrbeta2osb-/- mice treated with central leptin infusion at 4 ng/h for 1 wk. Error bars indicate mean + SEM. *, P < 0.05; **, P < 0.01. Control in A-C indicates Synapsin-Cre mice. Control in G-J and M indicates alpha1(I)Collagen-Cre mice.
###end p 20
###begin title 21
Leptin-dependent sympathetic regulation of insulin secretion occurs through the osteoblasts
###end title 21
###begin p 22
###xml 75 88 75 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">Iversen, 1973</xref>
###xml 344 363 344 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">Takeda et al., 2002</xref>
###xml 461 477 461 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">Lee et al., 2007</xref>
###xml 607 610 601 604 <sub xmlns:xlink="http://www.w3.org/1999/xlink">osb</sub>
###xml 610 613 604 607 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 599 613 596 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Adr&#946;2<sub>osb</sub><sup>&#8722;/&#8722;</sup></italic>
###xml 614 618 <span type="species:ncbi:10090">mice</span>
Although isoproterenol can affect secretion of insulin by isolated islets (Iversen, 1973), two reasons led us to test the hypothesis that it was also through the osteoblasts that the sympathetic tone, under the control of leptin, regulates insulin secretion. One is the functional link existing between leptin, sympathetic tone, and bone mass (Takeda et al., 2002), and another one is the recently uncovered role of osteoblasts in regulating insulin secretion (Lee et al., 2007). To test this hypothesis, we deleted Adrbeta2, the only adrenergic receptor expressed in osteoblasts, from these cells (Adrbeta2osb-/- mice).
###end p 22
###begin p 23
###xml 85 88 82 85 <sub xmlns:xlink="http://www.w3.org/1999/xlink">osb</sub>
###xml 88 91 85 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 77 91 77 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Adr&#946;2<sub>osb</sub><sup>&#8722;/&#8722;</sup></italic>
###xml 114 122 111 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 G</xref>
###xml 274 277 262 265 <sub xmlns:xlink="http://www.w3.org/1999/xlink">osb</sub>
###xml 277 280 265 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 266 280 257 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Adr&#946;2<sub>osb</sub><sup>&#8722;/&#8722;</sup></italic>
###xml 287 295 275 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 H</xref>
###xml 356 359 341 344 <sub xmlns:xlink="http://www.w3.org/1999/xlink">osb</sub>
###xml 359 362 344 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 348 362 336 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Adr&#946;2<sub>osb</sub><sup>&#8722;/&#8722;</sup></italic>
###xml 497 508 482 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Adiponectin</italic>
###xml 564 572 549 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Adr&#946;2</italic>
###xml 634 637 613 616 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 626 637 608 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Adr&#946;1<sup>&#8722;/&#8722;</sup></italic>
###xml 652 655 627 630 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 642 655 621 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Adr&#945;2A<sup>&#8722;/&#8722;</sup></italic>
###xml 689 692 661 664 <sub xmlns:xlink="http://www.w3.org/1999/xlink">osb</sub>
###xml 692 695 664 667 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 681 695 656 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Adr&#946;2<sub>osb</sub><sup>&#8722;/&#8722;</sup></italic>
###xml 733 740 705 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Insulin</italic>
###xml 745 756 717 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Glucokinase</italic>
###xml 821 836 793 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, I and J</xref>
###xml 843 847 815 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdk4</italic>
###xml 888 891 857 860 <sub xmlns:xlink="http://www.w3.org/1999/xlink">osb</sub>
###xml 891 894 860 863 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 880 894 852 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Adr&#946;2<sub>osb</sub><sup>&#8722;/&#8722;</sup></italic>
###xml 901 909 870 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 J</xref>
###xml 999 1004 968 973 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 1024 1032 993 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 D</xref>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
###xml 108 112 <span type="species:ncbi:10090">mice</span>
###xml 281 285 <span type="species:ncbi:10090">mice</span>
###xml 363 367 <span type="species:ncbi:10090">mice</span>
###xml 656 660 <span type="species:ncbi:10090">mice</span>
###xml 696 700 <span type="species:ncbi:10090">mice</span>
###xml 895 899 <span type="species:ncbi:10090">mice</span>
###xml 1005 1009 <span type="species:ncbi:10090">mice</span>
Consistent with our hypothesis, serum insulin levels were markedly higher in Adrbeta2osb-/- mice than in WT mice (Fig. 2 G and Fig. S2, available at ). Accordingly, propranolol, a beta blocker acting through Adrbeta2, increased insulin serum levels in WT but not in Adrbeta2osb-/- mice (Fig. 2 H). The increase in serum insulin levels developed in Adrbeta2osb-/- mice in the absence of any evidence of insulin resistance as determined by insulin tolerance test (ITT), serum adiponectin level, and Adiponectin expression in fat (Fig. S2, F-H). This was specific of Adrbeta2 deletion because serum insulin levels were normal in Adrbeta1-/- and Adralpha2A-/- mice (unpublished data). Adrbeta2osb-/- mice also had an 80-150% increase in Insulin and Glucokinase expression and exhibited postprandial low blood glucose levels (Fig. 2, I and J), and Cdk4 expression was increased 50% in Adrbeta2osb-/- mice (Fig. 2 J). It is worthwhile to note that these abnormalities were similar to the ones observed in ob/ob mice (compare with Fig. 1 D).
###end p 23
###begin p 24
###xml 138 146 138 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Adr&#946;2</italic>
###xml 162 168 159 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Leptin</italic>
###xml 264 267 258 261 <sub xmlns:xlink="http://www.w3.org/1999/xlink">osb</sub>
###xml 267 270 261 264 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 256 270 253 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Adr&#946;2<sub>osb</sub><sup>&#8722;/&#8722;</sup></italic>
###xml 275 280 269 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 317 320 308 311 <sub xmlns:xlink="http://www.w3.org/1999/xlink">osb</sub>
###xml 309 320 303 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Adr&#946;2<sub>osb</sub></italic>
###xml 320 323 311 314 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 328 330 319 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob</italic>
###xml 371 373 362 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob</italic>
###xml 384 387 372 375 <sub xmlns:xlink="http://www.w3.org/1999/xlink">osb</sub>
###xml 376 387 367 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Adr&#946;2<sub>osb</sub></italic>
###xml 387 390 375 378 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 470 485 458 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, K and L</xref>
###xml 561 566 549 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 586 601 574 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, B and C</xref>
###xml 628 635 616 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Insulin</italic>
###xml 682 687 670 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 692 694 680 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob</italic>
###xml 705 708 690 693 <sub xmlns:xlink="http://www.w3.org/1999/xlink">osb</sub>
###xml 697 708 685 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Adr&#946;2<sub>osb</sub></italic>
###xml 708 711 693 696 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 718 726 703 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 M</xref>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
###xml 281 285 <span type="species:ncbi:10090">mice</span>
###xml 333 337 <span type="species:ncbi:10090">mice</span>
###xml 391 395 <span type="species:ncbi:10090">mice</span>
###xml 567 571 <span type="species:ncbi:10090">mice</span>
###xml 712 716 <span type="species:ncbi:10090">mice</span>
If sympathetic signaling in osteoblasts and leptin are in the same genetic pathway, genetic epistasis predicts that mice heterozygous for Adrbeta2 deficiency and Leptin deficiency should harbor the same defect in insulin secretion than the one observed in Adrbeta2osb-/- and ob/ob mice. Indeed, although both Adrbeta2osb+/- and ob/+ mice had normal serum insulin levels, ob/+;Adrbeta2osb+/- mice displayed a hyperinsulinemia and lower blood glucose level after feeding (Fig. 2, K and L). The severity of these two abnormalities was only slightly milder than in ob/ob mice (compare with Fig. 1, B and C). At the molecular level, Insulin expression was elevated to the same degree in ob/ob and ob/+;Adrbeta2osb+/- mice (Fig. 2 M).
###end p 24
###begin p 25
###xml 320 323 317 320 <sub xmlns:xlink="http://www.w3.org/1999/xlink">osb</sub>
###xml 323 326 320 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 312 326 312 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Adr&#946;2<sub>osb</sub><sup>&#8722;/&#8722;</sup></italic>
###xml 333 341 330 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 N</xref>
###xml 519 522 513 516 <sub xmlns:xlink="http://www.w3.org/1999/xlink">osb</sub>
###xml 522 525 516 519 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 511 525 508 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Adr&#946;2<sub>osb</sub><sup>&#8722;/&#8722;</sup></italic>
###xml 532 547 526 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, O and P</xref>
###xml 327 331 <span type="species:ncbi:10090">mice</span>
###xml 526 530 <span type="species:ncbi:10090">mice</span>
To add further credence to the notion that sympathetic signaling in osteoblasts contributes to the leptin regulation of insulin secretion, we performed two other experiments. Long-term (1 wk) intracerebroventricular (ICV) infusion of 4 ng/h leptin decreased glucose-stimulated insulin secretion in WT but not in Adrbeta2osb-/- mice (Fig. 2 N). We also used a hyperglycemic clamp to assess glucose-stimulated insulin secretion in vivo. Leptin ICV infusion also decreased circulating insulin levels in WT but not Adrbeta2osb-/- mice (Fig. 2, O and P). Collectively, these observations identify sympathetic signaling in osteoblasts as a significant mediator of leptin's regulation of insulin secretion.
###end p 25
###begin title 26
The sympathetic tone in osteoblasts inhibits osteocalcin activity
###end title 26
###begin p 27
###xml 172 179 166 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Insulin</italic>
###xml 252 255 246 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esp</italic>
###xml 262 278 256 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">Lee et al., 2007</xref>
###xml 280 299 274 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">Ferron et al., 2008</xref>
How does sympathetic signaling in osteoblasts regulate insulin secretion in beta cells? Osteoblasts secrete osteocalcin, a molecule stimulating beta-cell proliferation and Insulin expression whose biological activity is decreased by the product of the Esp gene (Lee et al., 2007; Ferron et al., 2008). Multiple observations indicate that the leptin-dependent sympathetic regulation of insulin secretion occurs in part by modulating osteocalcin bioactivity.
###end p 27
###begin p 28
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esp</italic>
###xml 96 107 96 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Osteocalcin</italic>
###xml 151 159 151 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 237 245 237 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 B</xref>
###xml 373 389 373 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">Lee et al., 2007</xref>
###xml 414 419 414 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 432 435 429 432 <sub xmlns:xlink="http://www.w3.org/1999/xlink">osb</sub>
###xml 435 438 432 435 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 424 438 424 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Adr&#946;2<sub>osb</sub><sup>&#8722;/&#8722;</sup></italic>
###xml 445 453 442 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
###xml 696 701 693 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 773 780 770 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Insulin</italic>
###xml 871 879 868 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 D</xref>
###xml 439 443 <span type="species:ncbi:10090">mice</span>
Esp expression was up-regulated fourfold by isoproterenol in osteoblasts, whereas expression of Osteocalcin and of other enzymes modifying it was not (Fig. 3 A). Accordingly, and although the serum level of total osteocalcin was normal (Fig. 3 B), the amount of osteocalcin binding to hydroxyapatite (HA) with low affinity, i.e., undercarboxylated and biologically active (Lee et al., 2007), was increased in both ob/ob and Adrbeta2osb-/- mice (Fig. 3 C). Two control experiments validated this finding. First, when using serum containing only uncarboxylated osteocalcin as a negative control, osteocalcin eluted in the same fractions as the ones harboring an increased content of osteocalcin in ob/ob serum (unpublished data). Second, the low affinity fractions regulated Insulin expression in isolated islets, whereas the ones binding to HA with high affinity did not (Fig. 3 D).
###end p 28
###begin p 29
###xml 56 58 56 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 0 76 0 76 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Osteocalcin directly regulates insulin secretion in a Ca<sup>2+</sup>-dependent manner.</bold>
###xml 230 235 230 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 248 251 245 248 <sub xmlns:xlink="http://www.w3.org/1999/xlink">osb</sub>
###xml 251 254 248 251 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 240 254 240 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Adr&#946;2<sub>osb</sub><sup>&#8722;/&#8722;</sup></italic>
###xml 265 272 262 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Insulin</italic>
###xml 786 807 783 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#945;1(I)Collagen-Cre</italic>
###xml 255 259 <span type="species:ncbi:10090">mice</span>
###xml 808 812 <span type="species:ncbi:10090">mice</span>
Osteocalcin directly regulates insulin secretion in a Ca2+-dependent manner. (A) Gene expression in isoproterenol (ISO)- or leptin-treated osteoblasts. (B and C) Levels of total and uncarboxylated osteocalcin (HA low affinity) in ob/ob and Adrbeta2osb-/- mice. (D) Insulin expression by HA affinity fraction in islets. (E) Perifusion of WT islets in the presence of 0.03 ng/ml osteocalcin under a 3-mM glucose condition. (F) Intracellular calcium imaging assay using WT islets in the presence of osteocalcin under the different concentrations of glucose. (G) Insulin secretion by osteocalcin in WT islets maintained in either low or high glucose. (H) Gene expression in osteocalcin-treated islets. Error bars indicate mean + SEM. *, P < 0.05; **, P < 0.01. Control in B and C indicates alpha1(I)Collagen-Cre mice. In G, the concentration of glucose in the culture media is indicated in millimolars.
###end p 29
###begin p 30
###xml 180 188 180 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 E</xref>
###xml 306 307 306 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 326 328 326 328 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 556 558 556 558 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 651 653 651 653 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 711 712 711 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 718 726 718 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 F</xref>
###xml 898 906 898 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 G</xref>
###xml 936 943 936 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Insulin</italic>
###xml 948 959 948 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Glucokinase</italic>
###xml 980 988 980 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 H</xref>
###xml 396 401 <span type="species:ncbi:10090">mouse</span>
Next, we tested whether osteocalcin regulates insulin secretion directly. In an islets perifusion assay, 0.03 ng/ml uncarboxylated osteocalcin was a powerful insulin secretagogue (Fig. 3 E) with a strong first phase and a sustained but lower second phase of insulin secretion in all experiments performed (n = 3). Cytosolic Ca2+ imaging was also performed on untreated and osteocalcin-treated WT mouse islets at 3-, 8-, and 16-mM glucose levels. 30 mM KCl was used as a positive control. At 3 mM glucose, osteocalcin initiated a steady increase of basal Ca2+ concentration, whereas at 8 and 16 mM glucose, osteocalcin notably enhanced the cytosolic Ca2+ concentration as compared with control untreated islets (n = 3; Fig. 3 F and Fig. S3, available at ). Osteocalcin also augmented glucose-stimulated insulin secretion from isolated islets maintained in either low or high glucose concentrations (Fig. 3 G). In addition, expression of Insulin and Glucokinase in isolated islets (Fig. 3 H) was induced by osteocalcin in a time- and dose-dependent manner.
###end p 30
###begin p 31
###xml 200 205 200 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 250 255 250 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 269 272 269 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esp</italic>
###xml 274 279 274 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 283 286 283 286 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 280 286 280 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esp<sup>&#8722;/&#8722;</sup></italic>
###xml 294 299 294 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ob/ob</italic>
###xml 303 306 303 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 300 306 300 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esp<sup>&#8722;/&#8722;</sup></italic>
###xml 352 357 352 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 379 387 379 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 441 446 441 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 479 482 479 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esp</italic>
###xml 484 492 484 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 B</xref>
###xml 495 500 495 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ob/ob</italic>
###xml 504 507 504 507 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 501 507 501 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esp<sup>&#8722;/&#8722;</sup></italic>
###xml 603 608 603 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 709 728 709 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4, A, C, and D</xref>
###xml 849 854 849 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 858 861 858 861 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 855 861 855 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esp<sup>&#8722;/&#8722;</sup></italic>
###xml 873 878 873 878 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 885 893 885 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 E</xref>
###xml 983 988 983 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 992 995 992 995 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 989 995 989 995 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esp<sup>&#8722;/&#8722;</sup></italic>
###xml 1000 1005 1000 1005 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 206 210 <span type="species:ncbi:10090">mice</span>
###xml 256 260 <span type="species:ncbi:10090">mice</span>
###xml 287 291 <span type="species:ncbi:10090">mice</span>
###xml 307 311 <span type="species:ncbi:10090">mice</span>
###xml 358 362 <span type="species:ncbi:10090">mice</span>
###xml 447 451 <span type="species:ncbi:10090">mice</span>
###xml 508 512 <span type="species:ncbi:10090">mice</span>
###xml 609 613 <span type="species:ncbi:10090">mice</span>
###xml 691 696 <span type="species:ncbi:10090">mouse</span>
###xml 879 883 <span type="species:ncbi:10090">mice</span>
###xml 1006 1010 <span type="species:ncbi:10090">mice</span>
The relevance of osteocalcin in the leptin-dependent sympathetic regulation of insulin secretion was also verified in vivo. First, increasing osteocalcin bioactivity should worsen hyperinsulinemia in ob/ob mice. To test this hypothesis, we generated ob/ob mice lacking Esp (ob/ob;Esp-/- mice). Ob/ob;Esp-/- mice were twofold more hyperinsulinemic than ob/ob mice at 2 wk of age (Fig. 4 A). Remarkably, similar abnormalities were observed in ob/ob mice lacking only one allele of Esp (Fig. 4 B). Ob/ob;Esp-/- mice also had low blood glucose levels and remained significantly less glucose intolerant than ob/ob mice until 8 wk of age, thus illustrating the importance of this pathway in adult mouse physiology (Fig. 4, A, C, and D). An improved glucose tolerance was demonstrated by the ability of a glucose challenge to increase insulin secretion in ob/ob;Esp-/- but not in ob/ob mice (Fig. 4 E). Insulin sensitivity, as measured by hyperinsulinemic-euglycemic clamps, was similar in ob/ob;Esp-/- and ob/ob mice (Table S1, available at ).
###end p 31
###begin p 32
###xml 0 55 0 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Leptin regulates insulin secretion through osteoblasts.</bold>
###xml 93 98 93 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 102 105 102 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 99 105 99 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esp<sup>&#8722;/&#8722;</sup></italic>
###xml 142 147 142 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 151 154 151 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 148 154 148 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esp<sup>&#8722;/&#8722;</sup></italic>
###xml 193 198 193 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 202 205 202 205 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 199 205 199 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esp<sup>&#8722;/&#8722;</sup></italic>
###xml 252 257 252 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 261 264 261 264 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 258 264 258 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esp<sup>&#8722;/&#8722;</sup></italic>
###xml 325 330 325 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 334 337 334 337 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 331 337 331 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esp<sup>&#8722;/&#8722;</sup></italic>
###xml 398 403 398 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 407 410 407 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 404 410 404 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ocn<sup>&#8722;/&#8722;</sup></italic>
###xml 471 476 471 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 480 483 480 483 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 477 483 477 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ocn<sup>&#8722;/&#8722;</sup></italic>
###xml 558 563 558 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 567 570 567 570 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 564 570 564 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ocn<sup>&#8722;/&#8722;</sup></italic>
###xml 630 633 630 633 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 627 633 627 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ocn<sup>&#8722;/&#8722;</sup></italic>
###xml 733 736 733 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esp</italic>
###xml 106 110 <span type="species:ncbi:10090">mice</span>
###xml 155 159 <span type="species:ncbi:10090">mice</span>
###xml 206 210 <span type="species:ncbi:10090">mice</span>
###xml 265 269 <span type="species:ncbi:10090">mice</span>
###xml 338 342 <span type="species:ncbi:10090">mice</span>
###xml 411 415 <span type="species:ncbi:10090">mice</span>
###xml 484 488 <span type="species:ncbi:10090">mice</span>
###xml 571 575 <span type="species:ncbi:10090">mice</span>
###xml 634 638 <span type="species:ncbi:10090">mice</span>
Leptin regulates insulin secretion through osteoblasts. (A) Serum insulin in 2- and 8-wk-old ob/ob;Esp-/- mice. (B) Serum insulin in 2-wk-old ob/ob;Esp-/- mice. (C) Blood glucose in 2-8-wk-old ob/ob;Esp-/- mice. (D) Glucose tolerance tests in 2-mo-old ob/ob;Esp-/- mice. (E) Serum insulin after glucose challenge in 2-mo-old ob/ob;Esp-/- mice. (F and G) Serum insulin and blood glucose in 2-wk-old ob/ob;Ocn-/- mice. (H) Gene expression in pancreas or islets of 2-wk-old ob/ob;Ocn-/- mice. (I) Quantification of insulin/Ki67-positive cell islets of 2-wk-old ob/ob;Ocn-/- mice. (J) Serum insulin in 2-wk-old adipocyte-deficient;Ocn-/- mice. adp-def, adipocyte deficient. (K) In the presence of leptin, sympathetic tone is high; thus, Esp expression in the osteoblast is high, and osteocalcin bioactivity is low. This contributes to the inhibition of insulin secretion by leptin. Error bars indicate mean + SEM. *, P < 0.05; **, P < 0.01. 2W, 2 wk old; 4W, 4 wk old; 8W, 8 wk old; SNS, sympathetic nervous system.
###end p 32
###begin p 33
###xml 8 19 8 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Osteocalcin</italic>
###xml 107 112 107 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 119 124 119 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 136 139 136 139 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 125 139 125 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Osteocalcin<sup>&#8722;/&#8722;</sup></italic>
###xml 141 156 141 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4, F and G</xref>
###xml 173 180 173 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Insulin</italic>
###xml 182 193 182 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Glucokinase</italic>
###xml 199 203 199 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdk4</italic>
###xml 229 234 229 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 246 249 246 249 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 235 249 235 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Osteocalcin<sup>&#8722;/&#8722;</sup></italic>
###xml 269 274 269 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 327 332 324 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 344 347 341 344 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 333 347 330 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Osteocalcin<sup>&#8722;/&#8722;</sup></italic>
###xml 354 369 351 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4, H and I</xref>
###xml 424 429 421 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 441 444 438 441 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 430 444 427 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Osteocalcin<sup>&#8722;/&#8722;</sup></italic>
###xml 457 462 454 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 653 664 650 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Osteocalcin</italic>
###xml 751 759 748 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 J</xref>
###xml 113 117 <span type="species:ncbi:10090">mice</span>
###xml 250 254 <span type="species:ncbi:10090">mice</span>
###xml 275 279 <span type="species:ncbi:10090">mice</span>
###xml 348 352 <span type="species:ncbi:10090">mice</span>
###xml 445 449 <span type="species:ncbi:10090">mice</span>
###xml 463 467 <span type="species:ncbi:10090">mice</span>
###xml 745 749 <span type="species:ncbi:10090">mice</span>
Second, Osteocalcin inactivation decreased serum insulin levels 50% and normalized blood glucose levels in ob/ob mice (ob/ob;Osteocalcin-/-; Fig. 4, F and G). Expression of Insulin, Glucokinase, and Cdk4 was decreased 50-100% in ob/ob;Osteocalcin-/- mice compared with ob/ob mice, and beta-cell proliferation was normalized in ob/ob;Osteocalcin-/- mice (Fig. 4, H and I). The similarity of correction of hyperinsulinemia in ob/ob;Osteocalcin-/- mice and in ob/ob mice treated with the sympathomimetic isoproterenol supports the view that osteocalcin is in vivo a significant mediator of the leptin-dependent sympathetic regulation of insulin secretion. Osteocalcin inactivation also decreased serum insulin levels by half in adipocyte-deficient mice (Fig. 4 J). Collectively, the results presented in this study support the hypothesis that the leptin-dependent sympathetic inhibition of insulin secretion occurs in part via the osteoblast and acts by modulating osteocalcin activity.
###end p 33
###begin p 34
###xml 275 278 275 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esp</italic>
###xml 543 561 540 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">Covey et al., 2006</xref>
###xml 563 583 560 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">Morioka et al., 2007</xref>
###xml 866 880 863 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">Karsenty, 2006</xref>
###xml 882 893 879 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">Rosen, 2008</xref>
Our results reveal that leptin inhibits the endocrine function of the skeleton. Indeed, to a substantial extent, leptin's inhibition of insulin secretion relies on a three-step cascade, including (1) leptin's up-regulation of sympathetic tone, (2) sympathetic enhancement of Esp expression in osteoblasts, and (3) decrease in osteocalcin bioactivity. Osteocalcin acts in this context primarily by regulating insulin expression and secretion. These results do not contradict that leptin acts locally on beta cells to inhibit insulin secretion (Covey et al., 2006; Morioka et al., 2007); rather, they reveal an additional pathway whereby leptin fulfills this function. Beyond linking two secreted molecules, i.e., leptin and osteocalcin, these observations establish that the metabolic connection between osteoblasts and adipocytes is tighter than originally thought (Karsenty, 2006; Rosen, 2008). This cross talk includes an important functional component because osteoblasts mediate a significant part of one of the endocrine functions on adipocytes. This unexpected functional relationship between adipocytes, neurons, sympathetic tone, and osteoblasts illustrates in vivo the importance of the skeleton in the regulation of glucose homeostasis and provides an example of how critical the interplay is between multiple organs in the establishment and regulation of major physiological functions in vertebrates.
###end p 34
###begin title 35
Materials and methods
###end title 35
###begin title 36
Animals, treatments, and surgical procedures
###end title 36
###begin p 37
###xml 10 13 6 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 0 13 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Adr&#945;2A<sup>&#8722;/&#8722;</sup></italic>
###xml 89 92 85 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 78 92 74 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Osteocalcin<sup>&#8722;/&#8722;</sup></italic>
###xml 97 100 93 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 94 100 90 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esp<sup>&#8722;/&#8722;</sup></italic>
###xml 102 116 98 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lepr-flox/flox</italic>
###xml 122 143 118 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#945;1(I)Collagen-Cre</italic>
###xml 176 195 168 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">Altman et al., 1999</xref>
###xml 197 217 189 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">Dacquin et al., 2002</xref>
###xml 219 235 211 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">Lee et al., 2007</xref>
###xml 237 261 229 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">van de Wall et al., 2008</xref>
###xml 284 293 276 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Adr&#946;2-</italic>
###xml 312 315 298 301 <sub xmlns:xlink="http://www.w3.org/1999/xlink">osb</sub>
###xml 315 318 301 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 304 318 293 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Adr&#946;2<sub>osb</sub><sup>&#8722;/&#8722;</sup></italic>
###xml 420 441 406 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#945;1(I)Collagen-Cre</italic>
###xml 456 458 438 440 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ob</sup>
###xml 453 458 435 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lep<sup>ob</sup></italic>
###xml 784 801 766 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">Ducy et al., 2000</xref>
###xml 144 148 <span type="species:ncbi:10090">mice</span>
###xml 320 324 <span type="species:ncbi:10090">mice</span>
###xml 442 446 <span type="species:ncbi:10090">mice</span>
###xml 486 490 <span type="species:ncbi:10090">mice</span>
###xml 736 741 <span type="species:ncbi:9606">human</span>
Adralpha2A-/- (Q. Wang, University of Alabama at Birmingham, Birmingham, AL), Osteocalcin-/-, Esp-/-, Lepr-flox/flox, and alpha1(I)Collagen-Cre mice were previously described (Altman et al., 1999; Dacquin et al., 2002; Lee et al., 2007; van de Wall et al., 2008). Osteoblast-specific Adrbeta2-deficient (Adrbeta2osb-/-) mice were generated through homologous recombination in embryotic stem cells and through the use of alpha1(I)Collagen-Cre mice. B6.V-Lepob/J and FVB-Tg(AZIP/F)1Vsn/J mice were purchased from The Jackson Laboratory. 3 mg/kg isoproterenol was injected i.p. once daily for 2 wk. For ICV infusion, a 28-gauge cannula (brain infusion kit II; Alza) was implanted into the third ventricle as previously described, infusing human leptin (Sigma-Aldrich) at 4 ng/h for 7 d (Ducy et al., 2000). The cannula was connected to an osmotic pump (Alza) placed in the dorsal subcutaneous space of the animal. Genotyping was performed by PCR analysis of genomic DNA. All procedures involving animals were approved by the Institutional Animal Care and Use Committee and conform to the relevant regulatory standards.
###end p 37
###begin title 38
Metabolic studies
###end title 38
###begin p 39
###xml 581 586 581 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 588 593 588 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 597 600 597 600 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 594 600 594 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esp<sup>&#8722;/&#8722;</sup></italic>
###xml 626 627 626 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 784 785 784 785 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 808 809 808 809 <sc xmlns:xlink="http://www.w3.org/1999/xlink">d</sc>
###xml 813 815 813 815 <sup xmlns:xlink="http://www.w3.org/1999/xlink">14</sup>
###xml 851 867 851 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">Kim et al., 2004</xref>
###xml 878 881 875 878 <sub xmlns:xlink="http://www.w3.org/1999/xlink">osb</sub>
###xml 881 884 878 881 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 870 884 870 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Adr&#946;2<sub>osb</sub><sup>&#8722;/&#8722;</sup></italic>
###xml 903 904 900 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1179 1195 1164 1180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">Cho et al., 2007</xref>
###xml 226 230 <span type="species:ncbi:10090">mice</span>
###xml 545 550 <span type="species:ncbi:10090">Mouse</span>
###xml 620 624 <span type="species:ncbi:10090">mice</span>
###xml 897 901 <span type="species:ncbi:10090">mice</span>
For glucose tolerance tests, 0.625 or 2 g/kg glucose was injected i.p. after an overnight fast, and blood glucose was monitored using blood glucose strips and the Accu-Check glucometer (Roche) at the indicated times. For ITT, mice were injected i.p. with 0.25 or 0.5 U/kg insulin, and blood glucose levels were measured at the indicated times. ITT data are presented as a percentage of initial blood glucose concentration. Hyperinsulinemic-euglycemic clamps and hyperglycemic clamps were performed at the Pennsylvania State Diabetes and Obesity Mouse Phenotyping Center. In brief, ob/ob, ob/ob;Esp-/-, and WT littermate mice (n = 4 for each group) were fasted overnight, and a 2-h hyperinsulinemic (2.5 mU/kg/min)-euglycemic clamp was performed after intravenous administration of [3-3H] glucose and 2-deoxy-d-[1-14C] glucose as previously described (Kim et al., 2004). Adrbeta2osb-/- and control mice (n = 4 for each group) were fasted overnight, and a 2-h hyperglycemic clamp was conducted with a variable infusion of 20% glucose to maintain hyperglycemia at approximately300 mg/dl. Blood samples were taken at 10-20-min intervals for the measurement of plasma insulin levels (Cho et al., 2007).
###end p 39
###begin title 40
Islet perifusion
###end title 40
###begin p 41
###xml 56 72 56 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">Gao et al., 2007</xref>
###xml 114 118 <span type="species:ncbi:10090">mice</span>
Islet perifusion was performed as described previously (Gao et al., 2007). In brief, islets were isolated from WT mice using standard collagenase digestion followed by purification through a Ficoll gradient. 100 islets were hand picked under a light microscope and placed into a perifusion chamber (Millipore). A computer-controlled high performance liquid chromatography system (625 LC; Waters Corporation) allowed programmable rates of flow and concentration of the appropriate solutions held in a 37degreesC water bath. Islets were perifused with Krebs bicarbonate buffer to reach baseline hormone secretion values before the addition of the appropriate secretagogues. Samples were collected at regular intervals with a fraction collector (Waters Corporation).
###end p 41
###begin title 42
###xml 2 4 2 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
Ca2+ imaging
###end title 42
###begin p 43
###xml 12 14 12 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 62 78 62 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">Gao et al., 2007</xref>
###xml 554 556 542 544 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 81 86 <span type="species:ncbi:10090">Mouse</span>
Cytosolic Ca2+ imaging was performed as described previously (Gao et al., 2007). Mouse islets cultured for 3-4 d in 10 mM glucose were loaded with 1 mmol/liter fura 2-AM (Invitrogen) during a 40-min pretreatment at 37degreesC in Krebs buffer, transferred to the perifusion chamber, and placed on the homeothermic platform of an inverted microscope (Axio Observer Z1; Carl Zeiss, Inc.). Islets were perfused with Krebs buffer at 37degreesC while various treatments were applied. The microscope was used with a 40x oil immersion objective. Intracellular Ca2+ was determined by the ratio of the excitation of fura 2-AM at 334 and 380 nm. Emission was measured at 520 nm with a charge-coupled device camera (Attofluor; Invitrogen) and calibrated using the Ratio Vision software (Attofluor; Invitrogen).
###end p 43
###begin title 44
In vitro glucose-stimulated insulin secretion
###end title 44
###begin p 45
###xml 30 51 30 51 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">Kitamura et al., 2001</xref>
For assay of insulin release (Kitamura et al., 2001), five islets were manually selected, incubated in Krebs-Ringer solution, and stimulated at 37degreesC with various concentrations of glucose in the presence or absence of osteocalcin for 1 h. The islets were collected by centrifugation, and the supernatant was assayed for insulin content by ELISA (Crystal Chem).
###end p 45
###begin title 46
Cell and molecular studies
###end title 46
###begin p 47
###xml 89 108 89 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">Takeda et al., 2002</xref>
Primary osteoblasts were prepared from calvaria of 5-d-old pups as previously described (Takeda et al., 2002). Real-time PCR was performed on Dnase I-treated total RNA converted to cDNA using iTaq SYBR Green Supermix with ROX (6-carboxy-X-rhodamine; Bio-Rad Laboratories) on an MX3000 instrument; beta-actin amplification was used as an internal reference for each sample.
###end p 47
###begin title 48
Biochemistry
###end title 48
###begin p 49
Serum levels of insulin (Crystal Chem) and c-peptide (Yanaihara Institute) were measured using commercial kits. For quantification of uncarboxylated levels of osteocalcin, sera were incubated with HA slurry for 1 h. The quantity of osteocalcin present in the unbound fraction and in the fractions eluted at 0.02 and 1 M sodium phosphate, pH 6.8, was measured by an immunoradiometric assay (Immunotopics).
###end p 49
###begin title 50
Histology
###end title 50
###begin p 51
###xml 507 523 497 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">Lee et al., 2007</xref>
###xml 181 187 <span type="species:ncbi:9986">rabbit</span>
###xml 237 242 <span type="species:ncbi:10090">mouse</span>
Pancreas was fixed in 10% neutral formalin, embedded in paraffin, and sectioned at 5 mum; sections were stained with hematoxylin and eosin. Immunohistochemistry was performed using rabbit antiinsulin (Santa Cruz Biotechnology, Inc.) and mouse anti-Ki67 (Vector Laboratories) antibodies. beta-cell area represents the surface positive for insulin immunostaining divided by the total pancreatic surface. beta-cell mass was calculated as beta-cell area multiplied by pancreatic weight as described previously (Lee et al., 2007).
###end p 51
###begin title 52
Statistical analyses
###end title 52
###begin p 53
###xml 108 109 106 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
Results are given as means +/- SEM. Statistical analyses were performed using unpaired two-tailed Student's t or analysis of variance tests.
###end p 53
###begin title 54
Online supplemental material
###end title 54
###begin p 55
###xml 38 43 38 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 131 139 131 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Adr&#946;2</italic>
###xml 191 194 185 188 <sub xmlns:xlink="http://www.w3.org/1999/xlink">osb</sub>
###xml 194 197 188 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 183 197 180 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Adr&#946;2<sub>osb</sub><sup>&#8722;/&#8722;</sup></italic>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
###xml 150 154 <span type="species:ncbi:10090">mice</span>
###xml 198 202 <span type="species:ncbi:10090">mice</span>
###xml 278 282 <span type="species:ncbi:10090">mice</span>
Fig. S1 shows the characterization of ob/ob and adipocyte-deficient mice. Fig. S2 shows the strategy for generation of conditional Adrbeta2-deficient mice and the characterization of Adrbeta2osb-/- mice. Fig. S3 shows the intracellular calcium imaging performed on untreated WT mice islets at different concentrations of glucose. Online supplemental material is available at .
###end p 55
###begin title 56
Supplementary Material
###end title 56
###begin title 57
[Supplemental Material Index]
###end title 57
###begin p 58
###xml 25 29 <span type="species:ncbi:10090">mice</span>
We thank Dr. Q. Wang for mice and Dr. M. Ferron, P. Ducy, H. Liu, and G. Ren for technical assistance.
###end p 58
###begin p 59
This work was supported by the Japan Society for the Promotion of Science, the Uehara Memorial Foundation, the Kanae Foundation for the Promotion of Medical Science (grant to E. Hinoi), the National Institutes of Health (grants to G. Karsenty, K.H. Kaestner, and J.K. Kim), and the American Diabetes Association (grant to J.K. Kim). G. Karsenty is the founder of Escoublac, Inc.
###end p 59

